As of June 8, 2025, Chengdu Huasun Technology Group Co Ltd (000790.SZ) reports a ROE (Return on Equity) of -0.65%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Chengdu Huasun Technology Group Co Ltd's ROE (Return on Equity)
Over recent years, Chengdu Huasun Technology Group Co Ltd's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | -0.65% |
| 2023-12-31 | 2.68% |
| 2022-12-31 | 4.11% |
| 2021-12-31 | 5.67% |
| 2020-12-31 | 4.11% |
This slight downward trend highlights how Chengdu Huasun Technology Group Co Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Chengdu Huasun Technology Group Co Ltd's ROE (Return on Equity) to Peers
To better understand Chengdu Huasun Technology Group Co Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Chengdu Huasun Technology Group Co Ltd (000790.SZ) | -0.65% |
| Ji Yao Holding Group Co Ltd (300108.SZ) | 56.59% |
| Tibet Weixinkang Medicine Co Ltd (603676.SS) | 17.77% |
| Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452.SZ) | 13.20% |
| Hunan Fangsheng Pharmaceutical Co Ltd (603998.SS) | 12.81% |
| Hunan Hansen Pharmaceutical Co Ltd (002412.SZ) | 10.00% |
Compared to its competitors, Chengdu Huasun Technology Group Co Ltd's ROE (Return on Equity) is among the lowest compared to peers, which may indicate less effective deployment of shareholders' capital.